#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Loss of consciousness Neuroendocrine carcinoma metastatic Type IIa hyperlipidaemia Porphyria non-acute IgA nephropathy Hepatic angiosarcoma Arterial disorder Anti-HLA antibody test positive Mucopolysaccharidosis II Cholangiosarcoma Autoimmune disorder Adult T-cell lymphoma/leukaemia refractory Small intestine neuroendocrine tumour Haemophilia B with anti factor IX Retinitis pigmentosa More trials…

    Learn about Rare Diseases

    Alport’s syndrome Propionic acidaemia – Trials in Disease Angiosarcoma non-metastatic – Trials in Disease Netherton’s syndrome Vascular malformation – Treatment Wiskott-Aldrich syndrome – Life with Disease Medulloblastoma – Treatment Erdheim-Chester disease – Trials in Disease Adrenogenital syndrome – Trials in Disease Isodicentric chromosome 15 syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Valganciclovir STREPTOCOCCUS PYOGENES Ascorbic Acid Modafinil NALMEFENE HYDROCHLORIDE Mps-213 Colesevelam Sunvozertinib Sotalol Hydrochloride RO7284755 Bms-986442 Relebactam Clobetasol Prednisone Acetate Vamorolone HALOBETASOL PROPIONATE Cagrilintide CYCLIZINE HYDROCHLORIDE Utreglutide Certolizumab Pegol More therapies…

    Learn about Your Condition

    Infertility Ovarian granulosa cell tumour Menopausal symptoms Large cell lung cancer Marginal zone lymphoma Chordoma Plasmablastic lymphoma Death neonatal Malabsorption Lumbosacral radiculopathy Coronary artery occlusion H1N1 influenza Prader-Willi syndrome Tonsillitis Leukocyte adhesion deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Graalum

  • Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

    Recruiting

    4 1
    Investigated Drugs:
    • Clazakizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study of Hyperbaric Oxygen Therapy Combined with Standard Treatment for Patients with Sudden Hearing Loss

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Deafness neurosensory
    Investigated Drugs:
    • Nitrous Oxide
    • Oxygen
    Norway

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Safety and Pharmacodynamics of RBD4059 and Apixaban in Patients with Non‑Valvular Atrial Fibrillation: A Randomized Active‑Controlled Study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Rbd4059
    • Apixaban
    Denmark Norway Poland Sweden

  • A Phase 2 Study of Methylenedioxymethamphetamine‑Assisted Therapy in Young Adults (18‑25) with Chronic Treatment‑Resistant Major Depressive Disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Major depression
    Norway

  • A Phase 2b/3 Randomized Double‑Blind Study of Ataciguat to Slow Disease Progression in Adults with Moderate Calcific Aortic Valve Stenosis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Aortic valve stenosis
    Austria Czechia France Norway Poland Portugal +1
Previous Page
1 2 3 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Sodium Chloride Tenecteplase Nivolumab Apixaban Asundexian Dexamethasone Pembrolizumab Cisplatin Hydrocortisone Prednisone Abiraterone Acetate BENZYLPENICILLIN POTASSIUM Hyoscine Butylbromide Ketamine Entecavir Rituximab Botulinum Toxin Type A Selatogrel Enzalutamide BENZYLPENICILLIN PROCAINE Sodium Hydrogen Carbonate Acetylsalicylic Acid H2-Receptor Antagonists Vincristine Sulfate Erenumab Azd5004 Fludrocortisone Betamethasone Valerate Ianalumab Fremanezumab Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute myocardial infarction Alcohol use disorder Amyotrophic lateral sclerosis Aortic valve stenosis Arteriosclerosis Atrial fibrillation Bladder cancer Cancer pain Cardiac failure chronic Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic kidney disease Chronic obstructive pulmonary disease Cold type haemolytic anaemia Deafness neurosensory Depression Diffuse large B-cell lymphoma refractory Hormone-refractory prostate cancer Hypertension IgA nephropathy Immune thrombocytopenia Iron deficiency Ischaemic stroke Labour induction Lung disorder Major depression Malignant melanoma Metabolic dysfunction-associated steatohepatitis Metastatic neoplasm Migraine Monkeypox Non-alcoholic steatohepatitis Non-small cell lung cancer Non-small cell lung cancer metastatic Pancreatic carcinoma Plasma cell myeloma Pneumonia Primary adrenal insufficiency Renal cell carcinoma Retinal artery occlusion Sepsis Substance use disorder Thrombosis prophylaxis Transient ischaemic attack Transitional cell carcinoma metastatic Type 2 diabetes mellitus Type IIa hyperlipidaemia Warm autoimmune haemolytic anaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!